Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
12352203
NACRES:
NA.54
packaging
pkg of 15 plates (11989685001 [96 wells])
pkg of 5 plates (11645692001 [12 x 8 well strips and frame])
manufacturer/tradename
Roche
storage temp.
2-8°C
Quality Level
Related Categories
Analysis Note
SA leaching (bleeding): <5ng/well
Application
StreptaWell™ can be used for colorimetric and fluorescent protein immunoassays.
Features and Benefits
The unique coating process ensures homogenous and reproducible coatings with unique features:
- Little variances between individual wells (intra-assay variance)
- Little variances between different plates (inter-assay variance)
- High lot-to-lot reproducibility
- High signal-to-noise ratio
- Low background
- Almost no leaching
General description
Transparent, streptavidin-coated microplates with high binding capacity:
Total binding capacity: 1.5μg/well (biotin-labeled antibodies)
- Blocked volume: >300 μl
- SA-coated area: 300 μl
- Well geometry: C
Total binding capacity: 1.5μg/well (biotin-labeled antibodies)
Other Notes
For life science research only. Not for use in diagnostic procedures.
Legal Information
StreptaWell is a trademark of Roche
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
does not flash
flash_point_c
does not flash
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jean-Philippe Luzy et al.
Journal of biomolecular screening, 13(2), 112-119 (2008-01-25)
Adaptor proteins Grb7 and Grb2 have been implicated as being 2 potential therapeutic targets in several human cancers, especially those that overexpress ErbB2. These 2 proteins contain both a SH2 domain (Src homology 2) that binds to phosphorylated tyrosine residues
Gang-Ping Xue
Nucleic acids research, 30(15), e77-e77 (2002-07-26)
A rapid and quantitative DNA-binding assay was developed based on the translational fusion of a DNA-binding protein (DBP) with a Neocallimastix patriciarum beta-1,4-D-glucanase, CelD. CelD releases a fluorescent 4-methylumbelliferyl product from 4-methylumbelliferyl cellobioside. This hydrolysis activity was used to quantify
Ruth C Matthews et al.
Antimicrobial agents and chemotherapy, 47(7), 2208-2216 (2003-06-25)
Mycograb (NeuTec Pharma plc) is a human genetically recombinant antibody against fungal heat shock protein 90 (HSP90). Antibody to HSP90 is closely associated with recovery in patients with invasive candidiasis who are receiving amphotericin B (AMB). Using in vitro assays
Related Content
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service